Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:85-97
doi: 10.1161/CIRCULATIONAHA.106.678342
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schiffrin, E. L.
Right arrow Articles by Mann, J. F.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schiffrin, E. L.
Right arrow Articles by Mann, J. F.E.
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Other hypertension
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Other Vascular biology
Right arrow Risk Factors

(Circulation. 2007;116:85-97.)
© 2007 American Heart Association, Inc.


Cardiovascular Involvement in General Medical Conditions

Chronic Kidney Disease

Effects on the Cardiovascular System

Ernesto L. Schiffrin, MD, PhD, FRSC, FRCPC; Mark L. Lipman, MD, FRCPC; Johannes F.E. Mann, MD

From the Department of Medicine (E.L.S., M.L.L.), Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montreal, Quebec, Canada; and the Department of Nephrology and Hypertension (J.F.E.M.), Schwabing General Hospital, Ludwig Maximilians University, Munich, Germany.

Correspondence to Ernesto L. Schiffrin, MD, PhD, FRSC, FRCPC, Sir Mortimer B. Davis Jewish General Hospital, B-127, 3755 Côte Ste-Catherine Rd, Montreal, Quebec, Canada H3T 1E2. E-mail ernesto.schiffrin{at}mcgill.ca

Accelerated cardiovascular disease is a frequent complication of renal disease. Chronic kidney disease promotes hypertension and dyslipidemia, which in turn can contribute to the progression of renal failure. Furthermore, diabetic nephropathy is the leading cause of renal failure in developed countries. Together, hypertension, dyslipidemia, and diabetes are major risk factors for the development of endothelial dysfunction and progression of atherosclerosis. Inflammatory mediators are often elevated and the renin-angiotensin system is frequently activated in chronic kidney disease, which likely contributes through enhanced production of reactive oxygen species to the accelerated atherosclerosis observed in chronic kidney disease. Promoters of calcification are increased and inhibitors of calcification are reduced, which favors metastatic vascular calcification, an important participant in vascular injury associated with end-stage renal disease. Accelerated atherosclerosis will then lead to increased prevalence of coronary artery disease, heart failure, stroke, and peripheral arterial disease. Consequently, subjects with chronic renal failure are exposed to increased morbidity and mortality as a result of cardiovascular events. Prevention and treatment of cardiovascular disease are major considerations in the management of individuals with chronic kidney disease.


Key Words: atherosclerosis • hypertension • kidney • vasculature




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
J. R. Brown, R. P. Cochran, T. A. MacKenzie, A. P. Furnary, K. S. Kunzelman, C. S. Ross, C. W. Langner, D. C. Charlesworth, B. J. Leavitt, L. J. Dacey, et al.
Long-term survival after cardiac surgery is predicted by estimated glomerular filtration rate.
Ann. Thorac. Surg., July 1, 2008; 86(1): 4 - 11.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
H. M. Siragy and C. Xue
Local renal aldosterone production induces inflammation and matrix formation in kidneys of diabetic rats
Exp Physiol, July 1, 2008; 93(7): 817 - 824.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. N. Rodionov and S. R. Lentz
The Homocysteine Paradox
Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1031 - 1033.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. I. Yilmaz, M. Saglam, A. R. Qureshi, J. J. Carrero, K. Caglar, T. Eyileten, A. Sonmez, E. Cakir, Y. Oguz, A. Vural, et al.
Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin
Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1621 - 1627.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. Kanda, S. Wakino, K. Hayashi, and J. Plutzky
Cardiovascular Disease, Chronic Kidney Disease, and Type 2 Diabetes Mellitus: Proceeding with Caution at a Dangerous Intersection
J. Am. Soc. Nephrol., January 1, 2008; 19(1): 4 - 7.
[Full Text] [PDF]